Research statistics
Relamorelin research: publications and trials
At a glance
Publications, all years
34
Since 2011
Publications in 2026 so far
2
Through November 8, 2026
Human clinical research
29.4%
10 of 34 classified
Registered clinical trials
13
ClinicalTrials.gov
Randomized controlled trials
10
Publications reporting an RCT in people
Systematic reviews and meta-analyses
1
Preclinical studies
23.5%
6 animal · 0 in vitro · 2 computational
Records that only mention it
19
Not counted above
Status in the library: In clinical trials. Groups: Growth hormone axis.
What to keep in mind
- Some completed trials have neither posted results nor a linked results publication.
Publications by year
Relamorelin publications by year and evidence
Show the data
| Year | Human clinical research | Preclinical (animal, in vitro, computational) | Reviews and meta-analyses | Other and not yet classified | Total |
|---|---|---|---|---|---|
| 2011 | 0 | 1 | 0 | 0 | 1 |
| 2012 | 1 | 1 | 0 | 0 | 2 |
| 2013 | 1 | 1 | 0 | 0 | 2 |
| 2014 | 0 | 1 | 1 | 0 | 2 |
| 2015 | 2 | 1 | 2 | 0 | 5 |
| 2016 | 2 | 0 | 0 | 1 | 3 |
| 2017 | 2 | 0 | 4 | 0 | 6 |
| 2018 | 1 | 0 | 1 | 1 | 3 |
| 2019 | 0 | 0 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 0 | 2 | 3 |
| 2022 | 0 | 0 | 1 | 0 | 1 |
| 2023 | 0 | 0 | 2 | 0 | 2 |
| 2024 | 0 | 1 | 0 | 0 | 1 |
| 2026 (to date) | 0 | 2 | 0 | 0 | 2 |
Study types
| Review | 11 |
|---|---|
| Randomized controlled trial | 10 |
| Animal study | 6 |
| Editorial, letter or other | 4 |
| Computational study | 2 |
| Meta-analysis | 1 |
Research areas
From MeSH major topics. A paper can be in several areas.
| Gastrointestinal | 27 |
|---|---|
| Metabolic health | 11 |
| Endocrinology | 9 |
| Cardiovascular | 3 |
| Immune system | 3 |
| Neurological and mental health | 3 |
| Obesity and weight management | 3 |
| Musculoskeletal | 1 |
Registered clinical trials
1 of 7 trials completed at least a year before the cutoff have neither posted results nor a linked results publication. A registration is not a result.
Completed: 7 · Terminated: 6
Phase 1: 3 · Phase 2: 5 · Phase 3: 5
Human trials and evidence reviews
Meta-analyses, systematic reviews and trials in people, newest first.
- Effects of Promotility Agents on Gastric Emptying and Symptoms: A Systematic Review and Meta-analysis.
Gastroenterology · January 31, 2019 · Meta-analysis · cited 171 times
PMID 30711628 · DOI 10.1053/j.gastro.2019.01.249 · Reviews and meta-analyses
- Overall safety of relamorelin in adults with diabetic gastroparesis: Analysis of phase 2a and 2b trial data.
Alimentary pharmacology & therapeutics · April 17, 2020 · Randomized controlled trial · cited 41 times · open access
PMID 32301137 · DOI 10.1111/apt.15711 · Human clinical research
- Treatment With a Ghrelin Agonist in Outpatient Women With Anorexia Nervosa: A Randomized Clinical Trial.
The Journal of clinical psychiatry · January 1, 2018 · Randomized controlled trial · cited 74 times · open access
PMID 29325236 · DOI 10.4088/jcp.17m11585 · Human clinical research
- Efficacy and Safety of Relamorelin in Diabetics With Symptoms of Gastroparesis: A Randomized, Placebo-Controlled Study.
Gastroenterology · July 29, 2017 · Randomized controlled trial · cited 157 times · open access
PMID 28760384 · DOI 10.1053/j.gastro.2017.07.035 · Human clinical research
- A randomized trial of relamorelin for constipation in Parkinson's disease (MOVE-PD): Trial results and lessons learned.
Parkinsonism & related disorders · February 14, 2017 · Randomized controlled trial · cited 36 times
PMID 28237854 · DOI 10.1016/j.parkreldis.2017.02.003 · Human clinical research
- Effects of ghrelin receptor agonist, relamorelin, on gastric motor functions and satiation in healthy volunteers.
Neurogastroenterology and motility · June 9, 2016 · Randomized controlled trial · cited 57 times · open access
PMID 27283792 · DOI 10.1111/nmo.12870 · Human clinical research
- Relamorelin Reduces Vomiting Frequency and Severity and Accelerates Gastric Emptying in Adults With Diabetic Gastroparesis.
Gastroenterology · April 4, 2016 · Randomized controlled trial · cited 134 times
PMID 27055601 · DOI 10.1053/j.gastro.2016.03.038 · Human clinical research
- Short-Term Effects of Relamorelin on Descending Colon Motility in Chronic Constipation: A Randomized, Controlled Trial.
Digestive diseases and sciences · October 14, 2015 · Randomized controlled trial · cited 30 times
PMID 26467700 · DOI 10.1007/s10620-015-3876-5 · Human clinical research
- Relamorelin Relieves Constipation and Accelerates Colonic Transit in a Phase 2, Placebo-Controlled, Randomized Trial.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · May 19, 2015 · Randomized controlled trial · cited 49 times
PMID 26001337 · DOI 10.1016/j.cgh.2015.04.184 · Human clinical research
- The ghrelin agonist RM-131 accelerates gastric emptying of solids and reduces symptoms in patients with type 1 diabetes mellitus.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · April 30, 2013 · Randomized controlled trial · cited 109 times · open access
PMID 23639598 · DOI 10.1016/j.cgh.2013.04.019 · Human clinical research
Most cited
By OpenAlex citation count. Citations measure attention, not quality or correctness.
- Effects of Promotility Agents on Gastric Emptying and Symptoms: A Systematic Review and Meta-analysis.
Gastroenterology · January 31, 2019 · Meta-analysis · cited 171 times
PMID 30711628 · DOI 10.1053/j.gastro.2019.01.249 · Reviews and meta-analyses
- Efficacy and Safety of Relamorelin in Diabetics With Symptoms of Gastroparesis: A Randomized, Placebo-Controlled Study.
Gastroenterology · July 29, 2017 · Randomized controlled trial · cited 157 times · open access
PMID 28760384 · DOI 10.1053/j.gastro.2017.07.035 · Human clinical research
- Relamorelin Reduces Vomiting Frequency and Severity and Accelerates Gastric Emptying in Adults With Diabetic Gastroparesis.
Gastroenterology · April 4, 2016 · Randomized controlled trial · cited 134 times
PMID 27055601 · DOI 10.1053/j.gastro.2016.03.038 · Human clinical research
- Ghrelin and motilin receptors as drug targets for gastrointestinal disorders.
Nature reviews. Gastroenterology & hepatology · September 22, 2015 · Review · cited 129 times · open access
PMID 26392067 · DOI 10.1038/nrgastro.2015.163 · Reviews and meta-analyses
- The ghrelin agonist RM-131 accelerates gastric emptying of solids and reduces symptoms in patients with type 1 diabetes mellitus.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · April 30, 2013 · Randomized controlled trial · cited 109 times · open access
PMID 23639598 · DOI 10.1016/j.cgh.2013.04.019 · Human clinical research
Latest publications
- Ghrelin and relamorelin counteract hypoglycemia in mice engrafted with congenital hyperinsulinism stem cell-derived islets.
Stem cells translational medicine · July 1, 2026 · Animal study · cited 0 times · open access
PMID 42556326 · DOI 10.1093/stcltm/szag055 · Animal studies
- HighRes_Builder: improved access and modeling of noncanonical residues for protein structure prediction.
Briefings in bioinformatics · May 1, 2026 · Computational study · cited 1 times · open access
PMID 42218720 · DOI 10.1093/bib/bbag272 · Computational studies
- Peptide Drug Design Using Alchemical Free Energy Calculation: An Application and Validation on Agonists of Ghrelin Receptor.
Journal of chemical information and modeling · June 5, 2024 · Computational study · cited 2 times
PMID 38836743 · DOI 10.1021/acs.jcim.4c00414 · Computational studies
- Relamorelin in Gastroparesis and Diabetic Gastroparesis: A Meta-Analysis on Its Efficacy and Safety.
Cureus · November 5, 2023 · Review · cited 6 times · open access
PMID 38058346 · DOI 10.7759/cureus.48303 · Reviews and meta-analyses
- Diabetic Gastroparesis and its Emerging Therapeutic Options: A Narrative Review of the Literature.
Cureus · September 7, 2023 · Review · cited 7 times · open access
PMID 37814758 · DOI 10.7759/cureus.44870 · Reviews and meta-analyses
- Pharmacotherapeutic advances for chronic idiopathic constipation in adults.
Expert opinion on pharmacotherapy · November 27, 2022 · Review · cited 13 times
PMID 36408585 · DOI 10.1080/14656566.2022.2150076 · Reviews and meta-analyses
- Editorial: a need for glucose monitoring on prokinetic treatment with a ghrelin agonist in diabetic gastroparesis? Author's reply.
Alimentary pharmacology & therapeutics · August 1, 2020 · Editorial, letter or other · cited 0 times · open access
PMID 32656828 · DOI 10.1111/apt.15866 · Commentary and other
- Editorial: a need for glucose monitoring on prokinetic treatment with a ghrelin agonist in diabetic gastroparesis?
Alimentary pharmacology & therapeutics · August 1, 2020 · Editorial, letter or other · cited 1 times · open access
PMID 32656829 · DOI 10.1111/apt.15792 · Commentary and other
- Overall safety of relamorelin in adults with diabetic gastroparesis: Analysis of phase 2a and 2b trial data.
Alimentary pharmacology & therapeutics · April 17, 2020 · Randomized controlled trial · cited 41 times · open access
PMID 32301137 · DOI 10.1111/apt.15711 · Human clinical research
- Effects of Promotility Agents on Gastric Emptying and Symptoms: A Systematic Review and Meta-analysis.
Gastroenterology · January 31, 2019 · Meta-analysis · cited 171 times
PMID 30711628 · DOI 10.1053/j.gastro.2019.01.249 · Reviews and meta-analyses
How this is counted
PubMed records matched by the names below, counted when the peptide is in the title, indexed by MeSH, or confirmed from the abstract. The exact query can be rerun on Europe PMC. Methodology
Search terms: BIM-28131; Relamorelin; Relamorelina; Relamoreline; RM-131
((TITLE_ABS:"BIM-28131" OR CHEM:"BIM-28131" OR TITLE_ABS:"BIM28131" OR CHEM:"BIM28131") OR (TITLE_ABS:"Relamorelin" OR CHEM:"Relamorelin") OR (TITLE_ABS:"Relamorelina" OR CHEM:"Relamorelina") OR (TITLE_ABS:"Relamoreline" OR CHEM:"Relamoreline") OR (TITLE_ABS:"RM-131" OR CHEM:"RM-131" OR TITLE_ABS:"RM131" OR CHEM:"RM131")) AND SRC:MED
Cite this page
Peptide Library. (2026, November 9). Relamorelin research statistics (Version weekly-2026-11-08) [Statistic]. Peptide Library. https://peptidelibrary.app/research/peptides/relamorelin